Nanogrow Biotech
PrivateLast Round
Seed
Apr 29, 2024
Total Funding Raised
$1.2M
Company Overview
Nanogrow Biotech is a biotechnology company that provides research and development of single-domain antibodies for use in targeted treatments for the human and animal pharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanogrow Biotech Comps
Public and private peers based on sector, stage, and business model.
Nanogrow Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 29, 2024 |
Nanogrow Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GRIDX | Seed |
Nanogrow Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanogrow Biotech's valuation, stock price, and market status.
